Editorial: Hot topics in diabetes and steatotic liver disease
Non-alcoholic fatty liver disease (NAFLD), currently reframed as metabolic dysfunction-associated steatotic liver disease (MASLD), is one of the most prevalent...
Non-alcoholic fatty liver disease (NAFLD), currently reframed as metabolic dysfunction-associated steatotic liver disease (MASLD), is one of the most prevalent...
Following on from successful meetings in 2023 and 2024, the aims of this year’s meeting are to raise awareness about...
The U.S. Food and Drug Administration (FDA) on Friday issued a warning that Veozah (fezolinetant), a medicine used to treat...